Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: The SHASTA-2 Randomized Clinical Trial
Daniel Gaudet, Denes Pall, Gerald F. Watts, Stephen J. Nicholls, Robert S. Rosenson, Karen Modesto, Javier San Martin, Jennifer Hellawell, Christie M. Ballantyne
Dive into the research topics of 'Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: The SHASTA-2 Randomized Clinical Trial'. Together they form a unique fingerprint.